Literature DB >> 18783507

Assessing smoking status in children, adolescents and adults: cotinine cut-points revisited.

Martin J Jarvis1, Jennifer Fidler, Jennifer Mindell, Colin Feyerabend, Robert West.   

Abstract

AIMS: To reassess saliva cotinine cut-points to discriminate smoking status. Cotinine cut-points that are in use were derived from relatively small samples of smokers and non-smokers 20 or more years ago. It is possible that optimal cut-points may have changed as prevalence and exposure to passive smoking have declined.
DESIGN: Cross-sectional survey of the general population, with assessment of self-reported smoking and saliva cotinine. PARTICIPANTS: A total of 58 791 respondents aged 4 years and older in the Health Survey for England for the years 1996-2004 who provided valid saliva cotinine specimens. MEASURES: Saliva cotinine concentrations, demographic variables, self-reported smoking, presence or absence of smoking in the home, a composite index of social disadvantage derived from occupation, housing tenure and access to a car.
FINDINGS: A cut-point of 12 ng/ml performed best overall, with specificity of 96.9% and sensitivity of 96.7% in discriminating confirmed cigarette smokers from never regular smokers. This cut-point also identified correctly 95.8% of children aged 8-15 years smoking six or more cigarettes a week. There was evidence of substantial misreport in claimed ex-smokers, especially adolescents (specificity 72.3%) and young adults aged 16-24 years (77.5%). Optimal cut-points varied by presence (18 ng/ml) or absence (5 ng/ml) of smoking in the home, and there was a gradient from 8 ng/ml to 18 ng/ml with increasing social disadvantage.
CONCLUSIONS: The extent of non-smokers' exposure to other people's tobacco smoke is the principal factor driving optimal cotinine cut-points. A cut-point of 12 ng/ml can be recommended for general use across the whole age range, although different cut-points may be appropriate for population subgroups and in societies with differing levels of exposure to secondhand smoke.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18783507     DOI: 10.1111/j.1360-0443.2008.02297.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  63 in total

1.  Magnitude and Chronicity of Environmental Smoke Exposure Across Infancy and Early Childhood in a Sample of Low-Income Children.

Authors:  Lisa M Gatzke-Kopp; Michael T Willoughby; Siri M Warkentien; Thomas O'Connor; Douglas A Granger; Clancy Blair
Journal:  Nicotine Tob Res       Date:  2019-11-19       Impact factor: 4.244

2.  Persistent disparity in prevalence of current cigarette smoking between US adolescents with vs. without a past-year major depressive episode.

Authors:  Anthony P Polednak
Journal:  Community Ment Health J       Date:  2013-12-13

3.  Estimation of compliance with exclusive smoking of very low nicotine content cigarettes using plasma cotinine.

Authors:  J Foulds; A Hobkirk; E Wasserman; J Richie; S Veldheer; N M Krebs; L Reinhart; J Muscat
Journal:  Prev Med       Date:  2018-04-04       Impact factor: 4.018

4.  Whole body electronic cigarette exposure system for efficient evaluation of diverse inhalation conditions and products.

Authors:  Jay L Zweier; Mahmoud T Shalaan; Alexandre Samouilov; Ibrahim G Saleh; Mohamed A El-Mahdy
Journal:  Inhal Toxicol       Date:  2020-11-30       Impact factor: 2.724

Review 5.  Biomarkers of exposure to new and emerging tobacco delivery products.

Authors:  Suzaynn F Schick; Benjamin C Blount; Peyton Jacob; Najat A Saliba; John T Bernert; Ahmad El Hellani; Peter Jatlow; R Steven Pappas; Lanqing Wang; Jonathan Foulds; Arunava Ghosh; Stephen S Hecht; John C Gomez; Jessica R Martin; Clementina Mesaros; Sanjay Srivastava; Gideon St Helen; Robert Tarran; Pawel K Lorkiewicz; Ian A Blair; Heather L Kimmel; Claire M Doerschuk; Neal L Benowitz; Aruni Bhatnagar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-18       Impact factor: 5.464

6.  Developmental cigarette smoke exposure: hippocampus proteome and metabolome profiles in low birth weight pups.

Authors:  Rachel E Neal; Jing Chen; Rekha Jagadapillai; Hyejeong Jang; Bassam Abomoelak; Guy Brock; Robert M Greene; M Michele Pisano
Journal:  Toxicology       Date:  2014-01-28       Impact factor: 4.221

7.  Cotinine-assessed second-hand smoke exposure and risk of cardiovascular disease in older adults.

Authors:  B J Jefferis; D A Lawlor; S Ebrahim; S G Wannamethee; C Feyerabend; M Doig; L McMeekin; D G Cook; P H Whincup
Journal:  Heart       Date:  2010-06       Impact factor: 5.994

Review 8.  Recent contributions of air- and biomarkers to the control of secondhand smoke (SHS): a review.

Authors:  Jacques J Prignot
Journal:  Int J Environ Res Public Health       Date:  2011-03-01       Impact factor: 3.390

9.  Neurobehavioral phenotype of C57BL/6J mice prenatally and neonatally exposed to cigarette smoke.

Authors:  Robyn M Amos-Kroohs; Michael T Williams; Amanda A Braun; Devon L Graham; Cynthia L Webb; Todd S Birtles; Robert M Greene; Charles V Vorhees; M Michele Pisano
Journal:  Neurotoxicol Teratol       Date:  2013-01-11       Impact factor: 3.763

10.  Secondhand smoke (SHS) exposure is associated with circulating markers of inflammation and endothelial function in adult men and women.

Authors:  B J Jefferis; G D O Lowe; P Welsh; A Rumley; D A Lawlor; S Ebrahim; C Carson; M Doig; C Feyerabend; L McMeekin; S G Wannamethee; D G Cook; P H Whincup
Journal:  Atherosclerosis       Date:  2009-07-30       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.